Rachel Riechelmann and Guilherme Rossato
Apr 1, 2025, 10:10
Rachel Riechelmann and Guilherme Rossato discussion on treatment options for a patient with a pancreatic NET – Tumor Board Tuesday
Tumor Board Tuesday shared a post on X:
“Fresh off a recent FDA approval of a new agent for neuroendocrine tumors (NETs).
Join us on Tuesday, 04-01-25 at 8 pm ET as Rachel Riechelmann and Guilherme Rossato treatment options for a patient with a pancreatic NET.
RT and bring others into the discussion.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 14:08
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07